Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

CGTX - Cognition Therapeutics, Inc.... | Finranks

Home

/

CGTX

C

Cognition Therapeutics, Inc. (CGTX)

NCM – Real Time Price. Currency in USD

1.05

+0.04 (3.41%)

Market open: Aug 12, 2026, 2:44 PM EDT

1.01

-0.01 (-0.93%)

Previous after-hours: Aug 11, 2026, 7:39 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-228K

-266K

-252K

-235K

Gross Profit

-228K

-266K

-252K

-235K

Operating expenses (excl. COGS)

-48M

-54M

-50M

-43M

Operating Income

-48M

-54M

-51M

-44M

Non-operating income, total

24M

20M

25M

22M

Pretax income

-23M

-34M

-26M

-21M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-23M

-34M

-26M

-21M

Discontinued operations

0

0

0

0

Net income

-23M

-34M

-26M

-21M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

48M+60.1%

30M-14.0%

35M-30.3%

50M

Total current assets

48M

30M

34M

48M

Total non-current assets

399K

679K

941K

3M

Total liabilities

14M+22.9%

11M+7.4%

11M+5.0%

10M

Total current liabilities

14M

11M

10M

8M

Total non-current liabilities

195K

342K

520K

2M

Total equity

34M

19M

24M

40M

Total liabilities & shareholders' equities

48M

30M

35M

50M

Total debt

638K+19.3%

535K+207.5%

174K-90.5%

2M

Name

2025

2024

2023

2022

Cash from operating activities

-25M

-28M

-16M

-19M

Cash from investing activities

9K

-4K

-147K

-171K

Cash from financing activities

37M

24M

5M

6M

Free cash flow

-25M+13.7%

-28M-76.2%

-16M+13.6%

-19M